In-house developed PROSE lens help restore the vision of a 3-year-old
In collaboration with the Boston Foundation for Sight, USA, LVPEI is the only facility in India to manufacture speciality Scleral and PROSE contact lenses. LVPEI’s Vijayawada campus became the first in the country to use PROSE lenses on a paediatric patient. Hethwik was brought to the Vijayawada campus after he sustained a severe eye injury that could have robbed him of his vision caused due to an accidental fall from the bed. A scleral tear repair surgery was performed, post which he was diagnosed with irregular astigmatism (the curvature of the cornea/lens of his eye was imperfect) that could have worsened if not treated in time. Speciality contact lens ‘PROSE’ that are best suited for patients with injuries was provided to him free-of-cost. It helped in restoring his vision and in the healing process. Technology innovation and product development at LVPEI focus on bringing down the cost of healthcare and making high-quality eye care accessible to the community regardless of geographic and monetary challenges.
ConnectCare, an app-based teleconsultation service enabled over 50,000 patient consultations (saving about INR 60 millions in travel cost) and over a million kilos of carbon emissions, this year. ConnectCare enables patients to consult their doctors at LVPEI right from the comfort of their homes through phone or a video call.
Currently deployed in seven LVPEI locations, an in-house developed Cerebro Kiosk has completed over 100,000 self-check-ins. It not only enhanced the overall efficiency of patient care services, but also saved 7000 plus employee work hours and handled transactions worth millions.
BioNEST – LVPEI’s healthcare incubation centre reengineered accessories and consumables like LED light for slit lamps, artificial eye chambers, DMEK tubes, and SS trephines at 20X lesser cost than their imported equivalent. The first-of-its kind hospital-based healthcare incubator in India, it is capable of end-to-end prototyping with a special focus on ophthalmology. This world-class facility with micron precision machining centre, SLA 3D printing, electronics assembly & testing capabilities is now open for manufacturing products for other hospitals.
Award-winning visual field screening device Order of Magnitude (OM) has crossed the mark of screening over 100,000 eyes since its inception. This smart device can detect more than 60% of the common causes of avoidable blindness, including glaucoma.
Pupil-X, a virtual reality-based screening system for Neuro-Ophthalmology has completed over 2000 tests across the LVPEI network since its inception. Pupillary measurements derived from this device are objective & quantifiable and only take about 5 minutes for a much more consistent Pupillary Light Reflex test against a conventional 20-minute test with potentially varying results - from clinic to clinic.
Award-winning visual field screening device Order of Magnitude (OM) has crossed the mark of screening over 100,000 eyes since its inception. This smart device can detect more than 60% of the common causes of avoidable blindness, including glaucoma.
